Arbutus Biopharma (ABUS) Change in Cash (2013 - 2026)
Arbutus Biopharma (ABUS) posted Change in Cash of $5.7 million for Q1 2026, up 229.5% sequentially from -$4.4 million in Q4 2025, and up 663.81% YoY from $746000.0 in Q1 2025.
Arbutus Biopharma (ABUS) Change in Cash (2013 - 2026) Analysis & Trends
Arbutus Biopharma has reported Change in Cash for 14 years, with the latest figure at $5.7 million in Q1 2026.
- Quarterly Change in Cash rose 663.81% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.4 million (down 121.91% YoY) and the FY2025 annual result came in at -$18.3 million, down 282.4% from the prior year.
- Change in Cash rose to $5.7 million in Q1 2026 per ABUS's latest filing, from -$4.4 million in the prior quarter.
- Over five years, Change in Cash peaked at $19.7 million in Q2 2024 and troughed at -$34.0 million in Q2 2022.
- A 5-year average of -$5.0 million and a median of $336000.0 in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2026: Change in Cash sank 220.11% in 2024, then surged 663.81% in 2026.
- Over 5 years, Change in Cash stood at $6.8 million in 2022, then gained by 29.27% to $8.8 million in 2023, then sank by 48.78% to $4.5 million in 2024, then tumbled by 198.13% to -$4.4 million in 2025, then soared by 229.5% to $5.7 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $5.7 million, -$4.4 million, and -$15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - | -4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.54 Mn |
| Mar 31, 2026 | 5.70 Mn |
| Dec 31, 2025 | -4.40 Mn |
| Sep 30, 2025 | -15.00 Mn |
| Jun 30, 2025 | 336,000.00 |
| Mar 31, 2025 | 746,000.00 |
| Dec 31, 2024 | 4.48 Mn |
| Sep 30, 2024 | -30.94 Mn |
| Jun 30, 2024 | 19.69 Mn |
| Mar 31, 2024 | 16.82 Mn |
| Dec 31, 2023 | 8.75 Mn |
| Sep 30, 2023 | -9.67 Mn |
| Jun 30, 2023 | -13.38 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 6.77 Mn |
| Sep 30, 2022 | -23.32 Mn |
| Jun 30, 2022 | -34.01 Mn |
| Mar 31, 2022 | -27.95 Mn |
| Dec 31, 2021 | 31.40 Mn |
| Sep 30, 2021 | 46.93 Mn |